Glomerulonephritis
Findings from Aachen University advance knowledge in glomerulonephritis
Published in Hospital Business Week, February 10th, 2008
"To address this issue, ERK activity was blocked both in vitro in mesangial cells (MC) and in vivo in experimental glomerulonephritis (GN) by a pharmacological inhibitor (U0126) of the ERK-activating kinase. In stimulated MC, inhibition of ERK reduced cyclin-dependent kinase 2 (CDK2) phosphorylation, CDK2 activity and cyclin E/A expression, whereas downregulation of CDK inhibitor p27(Kip1) expression was inhibited....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
More Articles from Hospital Business Week
- Advanced Instruments, Inc.
Free White Paper Available for Clinical Laboratory Managers: 'Effectively Isolating Anaerobic Bacteria' - Adverse Drug Reactions
Bayer Establishes US Special Access Program for Leukine(R) While Replacing Current Liquid Formulation - Adverse Drug Reactions
Researchers from RAND Corporation describe findings in adverse drug reactions - Aegis Health Group
Aegis Announces Creation of a Physician Services Division; Hospitals in California and Tennessee Become First to Avail Themselves of Company's New Services - Aging
Report: Too Few Physicians, Nurses to Implement Presidential Candidates' Health Reform Plans - Allergies
Study Says Allergy Shots Help Children, Reduce Health Care Costs - More from this issue of Hospital Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
